Henrietta, NY – Turbett Surgical has announced the appointment of Kevin Danahy as President and Chief Executive Officer. About Turbett Surgical: Turbett Surgical specializes in innovative sterilization solutions for surgical instruments, offering Instrument Pods tailored…
Rochester, NY – Transcat Inc. has announced the appointment of Jaime Irick as President and Chief Executive Officer. About Transcat Inc.: Transcat Inc. is a leading provider of accredited calibration, repair, inspection, reliability, maintenance optimization,…
Rochester, New York — According to state and local development sources, Reju plans to invest $390,000,000.00 to expand in Rochester. The company plans to occupy the new space at TBD in Rochester, on or about…
Batavia, NY – Graham Corporation has announced the appointment of Keith Oufnac as Chief Information Officer. About Graham Corporation: Graham Corporation (NYSE: GHM) is a global leader specializing in the design and manufacture of mission-critical…
Batavia, NY – Graham Corporation has announced the appointment of William Zmyndak as Deputy General Manager of Graham Manufacturing. About Graham Corporation: Graham Corporation (NYSE: GHM) is a global leader specializing in the design and…
Batavia, NY – Graham Corporation has announced the appointment of Rachel Jaakkola as Chief Human Resources Officer. About Graham Corporation: Graham Corporation (NYSE: GHM) is a global leader specializing in the design and manufacture of…
Rochester, New York — According to state and local development sources, Reju plans to invest $390 Million to build out 145,000 square feet of new space in Rochester. The company plans to occupy the new…
Cytotheryx’s Series A financing, alongside strategic debt funding, will advance its cell therapy programs toward clinical development and support GMP manufacturing scale-up. ROCHESTER, Minn., Jan. 12, 2026 /PRNewswire/ — Cytotheryx, Inc. , a preclinical cell therapy company developing cell-based…
ROCHESTER, Minn.–(BUSINESS WIRE)–Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, today announced the closing of the $25M final tranche to its Series B financing, bringing the total…
According to filings with the U.S. Securities and Exchange Commission, VM Agritech Inc. is raising up to $17,606,040.00 in new funding. The federal securities law requires the notice to be filed by companies that have…